Matches in Ghent University Academic Bibliography for { <https://biblio.ugent.be/publication/01GJ306J3NAF5KTJZJRMA716ZN> ?p ?o. }
Showing items 1 to 32 of
32
with 100 items per page.
- 01GJ306J3NAF5KTJZJRMA716ZN classification A1.
- 01GJ306J3NAF5KTJZJRMA716ZN date "2023".
- 01GJ306J3NAF5KTJZJRMA716ZN language "eng".
- 01GJ306J3NAF5KTJZJRMA716ZN type journalArticle.
- 01GJ306J3NAF5KTJZJRMA716ZN hasPart 01GJ307GYQ4088T78WK36ABSED.pdf.
- 01GJ306J3NAF5KTJZJRMA716ZN subject "Medicine and Health Sciences".
- 01GJ306J3NAF5KTJZJRMA716ZN doi "10.1016/j.jaip.2022.10.040".
- 01GJ306J3NAF5KTJZJRMA716ZN issn "2213-2198".
- 01GJ306J3NAF5KTJZJRMA716ZN issn "2213-2201".
- 01GJ306J3NAF5KTJZJRMA716ZN issue "2".
- 01GJ306J3NAF5KTJZJRMA716ZN volume "11".
- 01GJ306J3NAF5KTJZJRMA716ZN abstract "BACKGROUND: It is unclear whether patients with asthma benefit from stepping up to high-dose inhaled corticosteroids (ICS).; OBJECTIVE: To determine the effectiveness of stepping up to high-dose ICS.; METHODS: A historic cohort study of asthma patients (≥13 years old), identified from two large UK electronic medical record databases, was conducted. Patients who remained on medium-dose ICS were compared to those who stepped up from medium- to high-dose ICS, while patients who stepped up from low- to medium-dose were compared to those who stepped up from low- to high-dose ICS. Time to first severe exacerbation (primary outcome) between treatment groups was compared using multivariable Cox proportional hazards models, and number of exacerbations and antibiotics courses were analyzed using negative binomial regression. Inverse probability of treatment weighting was used to handle confounding.; RESULTS: The mean follow-up time to first exacerbation was 2.7 (SD 2.7) years for those who remained on stable medium-dose ICS and 2.0 (SD 2.2) years for those who stepped up from medium-to high-dose ICS. A similar pattern was noted for those who stepped-up from low- to medium-ICS dose (2.6 (SD 2.5) years) and from low- to high-dose ICS (2.3 (SD 2.5) years). Patients who stepped up from medium- to high-dose ICS (n=6,879) had a higher risk of exacerbations during follow-up compared to those who remained on medium-dose ICS (n=51,737; hazard ratio [HR] 1.17, 95% confidence interval 1.12-1.22). This was similar in patients stepping up from low- to high-dose (n=3,232) compared to low- to medium-dose (n=12,659) ICS (HR 1.10 [1.04-1.17]). A step-up to high-dose ICS was also associated with higher number of asthma exacerbations and antibiotics courses. No significant difference in associations was found across subgroups of patients with different blood eosinophil counts (BEC).; CONCLUSION: We found no evidence that a step-up to high-dose ICS is effective in preventing future asthma exacerbations. Copyright © 2022. Published by Elsevier Inc.".
- 01GJ306J3NAF5KTJZJRMA716ZN author F497BC5E-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:11d86bd4-716b-4cc3-b317-407438668343.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:50f5d24f-8072-4d56-ad96-92ddc181a5ff.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:5a1f3369-c3c0-4b63-9f17-ab4ea59686a6.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:5b943099-b4c5-4142-bdfb-63138e304728.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:8fbd2845-ac4a-469c-b3ca-64ffd81dde29.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:9e31e36d-4e7c-47fc-b52f-9d7f973de835.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:c42b7ec0-d74e-4a22-b2f2-f89cd74e6a0e.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:c522180c-2900-4083-875b-389a2fbf6c36.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:dbced11d-cf08-4b69-b32a-3bb3e62e9fd3.
- 01GJ306J3NAF5KTJZJRMA716ZN author urn:uuid:f9619f46-eb64-458c-b625-7f21110e3933.
- 01GJ306J3NAF5KTJZJRMA716ZN dateCreated "2022-11-17T14:34:32Z".
- 01GJ306J3NAF5KTJZJRMA716ZN dateModified "2024-12-12T17:54:21Z".
- 01GJ306J3NAF5KTJZJRMA716ZN name "Effect of stepping up to high-dose inhaled corticosteroids in patients with asthma : UK database study".
- 01GJ306J3NAF5KTJZJRMA716ZN pagination urn:uuid:69756e98-1c1d-49f0-88a4-17688c2472e4.
- 01GJ306J3NAF5KTJZJRMA716ZN sameAs LU-01GJ306J3NAF5KTJZJRMA716ZN.
- 01GJ306J3NAF5KTJZJRMA716ZN sourceOrganization urn:uuid:74397ad7-50f7-47ac-b1a7-97943dab36fc.
- 01GJ306J3NAF5KTJZJRMA716ZN sourceOrganization urn:uuid:e890cd5e-3fc1-47a3-a4c5-6e1015232ef8.
- 01GJ306J3NAF5KTJZJRMA716ZN sourceOrganization urn:uuid:e92f61c0-0429-4506-b1e6-e6f715a270c0.
- 01GJ306J3NAF5KTJZJRMA716ZN type A1.